U.S. Construction Stock News

Evolv Technologies Holdings (EVLV) just landed a multi-year role as the official fan screening provider for Northwestern University’s new Ryan Field, placing its Evolv Express system at the center of a high-visibility stadium opening. See our latest analysis for Evolv Technologies Holdings. That new Ryan Field contract arrives during a mixed period for Evolv Technologies Holdings, with the share price at US$6.13 after a 10.85% 7 day share price return but a year to date share price return...

Solventum stock has quietly put up a 13.1% return over the past year, and the valuation checks now suggest the shares lean toward the cheaper side rather than looking stretched after that move. Over the past 12 months Solventum has returned 13.1%, which is enough to make the current pricing worth a closer look rather than assuming it is either a bargain or overheated. The planned separation of the Health Information Systems software business may support a sharper focus on MedTech returns...

Agilysys, Inc. reported past first-quarter 2026 results with revenue of US$87.68 million and net income of US$8.99 million, materially higher than a year earlier, and raised its fiscal 2027 revenue and subscription growth guidance. The combination of stronger profitability and higher full-year subscription growth targets points to increasing operating leverage in Agilysys’ hospitality software model. Next, we’ll explore how this stronger quarter and higher full-year revenue outlook may...

In August 2026, Pharvaris reported that its first in-depth qualitative study of patients with acquired C1 inhibitor deficiency (AAE-C1INH) was published in Frontiers in Immunology, detailing disease burden and validating patient-reported outcome tools for this ultra-rare condition with no approved therapies. The study’s insights directly informed endpoint selection for Pharvaris’s ongoing Phase 3 CREAATE trial of deucrictibant, potentially strengthening how future clinical benefits are...

In early August 2026, Monte Rosa Therapeutics, Inc. reported second-quarter results showing its net loss widened to US$43.4 million, with basic and diluted loss per share from continuing operations of US$0.43, and a first-half net loss of US$87.9 million versus net income a year earlier. The sharp shift from profit to loss over six months highlights growing cost intensity and brings funding requirements and potential dilution risk into sharper focus for investors. Against this backdrop,...

Everforth stock has rebounded sharply in the past month, yet multiple valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model both still point to the shares trading below what the fundamentals imply. Everforth is up 83.7% over the past month, which sharply changes the recent share price picture but still leaves longer term returns weak. The key support for valuation is the market's expectation that Everforth can turn its business performance into stronger...

Why NewMarket earnings and buybacks matter for shareholders now NewMarket (NEU) just released second quarter 2026 results alongside a buyback progress update, providing fresh data on profitability, cash deployment, and how management is handling capital returns. The company reported second quarter sales of US$747.09 million and net income of US$133.75 million, with basic earnings per share from continuing operations of US$14.54. These figures sit alongside a completed multi year repurchase...

PG&E stock moves after recent performance shift PG&E (PCG) has drawn fresh attention after a recent shift in its share performance, with the stock closing at $17.46 on 6 August 2026. Investors are weighing this price against the company’s longer term returns and fundamentals. See our latest analysis for PG&E. PG&E’s recent 2.7% one-day share price return at $17.46 sits alongside a 90-day share price return of 7.7% and a one-year total shareholder return of 17.6%, suggesting momentum has been...

In the past quarter, American Tower Corporation reported second-quarter 2026 revenue of US$2,749.1 million and net income of US$867.5 million, both higher than a year earlier, and it revised its full-year 2026 guidance for total property revenue to US$10.70–US$10.85 billion and net income to US$3.27–US$3.35 billion. Alongside this earnings strength and higher guidance, the company continued its long-running share repurchase program, retiring about 3.19 million shares since 2017, which...

Consumers are moneymaxxing, trimming impulse buys and leaning on apps to squeeze more value from every dollar. That shift puts pressure on old spending habits and also shines a spotlight on companies that help people budget, save, and manage cash flow more effectively. This article walks through three stocks from a fintech and personal finance technology screener that appear closely linked to this trend and explains why they may deserve a closer look now. The stocks highlighted below are just...

Uranium Royalty (NasdaqCM:UROY) has appointed Kevin McQuilkin and Peter Rozenauers to its Board of Directors to support continued growth and oversee corporate transformation. The new directors bring experience across mining, finance, and resource management at a time when Uranium Royalty is working through recent restructuring steps. The Board refresh follows transformational corporate actions, including an SEC deregistration and a combination with Orion, and is intended to reinforce...

In early August 2026, Wynn Resorts reported second-quarter revenue of US$1,856.93 million and net income of US$140.06 million, alongside a US$0.25 per-share dividend and completion of a long-running US$2.74 billion share repurchase program. The combination of higher earnings per share from continuing operations and meaningful capital returns via dividends and buybacks highlights Wynn’s emphasis on strengthening shareholder value while it continues to invest in major projects like Wynn Al...

Why this leadership and capital return update matters for Valmont Industries Valmont Industries (VMI) has combined a planned Board transition, an update on its share repurchase activity, and a fresh dividend declaration, giving investors several governance and capital return signals to weigh together. See our latest analysis for Valmont Industries. Against this backdrop, Valmont Industries’ recent shareholder friendly actions come after a period where the share price has risen 19.9% year to...

Unusual Machines, Inc. reported its second‑quarter 2026 results on August 6, showing sales rising to US$16.72 million from US$2.12 million a year earlier, while quarterly net loss widened to US$7.78 million and basic loss per share from continuing operations improved to US$0.16 from US$0.32. For the first half of 2026, the company generated sales of US$24.82 million and moved from a US$10.23 million net loss a year ago to net income of US$2.5 million, highlighting a sharp swing in...

Celanese Corporation recently reported past second-quarter 2026 results showing sales of US$2,752 million versus US$2,532 million a year earlier, while net income fell to US$125 million from US$197 million and diluted earnings per share from continuing operations declined to US$1.15 from US$1.89. Alongside this earnings pressure, the Amsterdam District Court dismissed in full the ethylene-related damages and liability claims against Celanese, removing a legal overhang stemming from earlier...

Chesapeake Utilities Corporation recently reported second-quarter 2026 results showing higher sales of US$209.5 million, revenue of US$201.9 million, and net income of US$25.4 million, while also reaffirming its 2028 earnings guidance of US$7.75–US$8.00 per share and declaring a US$0.735 quarterly dividend to be paid in October 2026. The company coupled these earnings gains with a larger capital program, including increased 2026 spending guidance and continued advancement of the US$1.20...

In early August 2026, Red Cat Holdings reported very large year-over-year Q2 revenue growth to US$20.19 million but a wider net loss of US$35.26 million, while reaffirming full-year 2026 revenue guidance in the US$150 million to US$180 million range. At the same time, its Blue Ops unit completed integrating a Volvo Penta D4-320 diesel engine and DPI drive into the Variant 7 uncrewed surface vessel, underscoring Red Cat’s push to build a flexible portfolio across air, sea, land and space...

Why Universal Display stock is back in focus Universal Display (OLED) is drawing fresh attention after second quarter results showed lower revenue and net income than a year earlier, alongside guidance now pointing to the lower end of its prior 2026 revenue range. See our latest analysis for Universal Display. Despite the softer outlook, Universal Display’s recent earnings update and guidance shift have come alongside a sharp short term rebound, with a 7 day share price return of 13.76% and a...

CareTrust REIT (CTRE) is back in focus after raising its 2026 earnings guidance alongside second quarter results that included higher normalized funds from operations and record investment activity across skilled nursing, U.K. care homes and SHOP assets. See our latest analysis for CareTrust REIT. After the updated 2026 guidance and record second quarter investments, CareTrust REIT’s 1 month share price return of 2.49% and year to date share price return of 13.52% suggest constructive...

Everpure stock has delivered very strong gains over the past few years, while the valuation checks now send mixed signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, yet the earnings multiple view leans expensive and the overall value score is low. Everpure has returned 351.8% over 5 years, which puts current buyers squarely focused on whether that pace is already reflected in the price. The market's optimism around Everpure's ability to keep turning...

In early August 2026, Natera reported second-quarter revenue of US$752.75 million with higher testing volumes and narrower losses, raised full-year 2026 revenue guidance to US$2.85 billion–US$2.91 billion, and filed an US$849.22 million shelf registration for 3,200,000 common shares tied to an ESOP offering. At the same time, Natera moved to deepen Signatera’s role in oncology by seeking Japanese approval of the test as a companion diagnostic in muscle-invasive bladder cancer, extending its...

In the past quarter, XPO, Inc. reported second-quarter 2026 results with sales of US$2,355 million and net income of US$162 million, alongside completing a US$224.99 million share repurchase and adding industry veteran Michael Kneeland to its board. This combination of stronger earnings, ongoing buybacks, and added board expertise may influence how investors assess XPO’s operations and capital allocation. We’ll now examine how XPO’s higher quarterly earnings per share might reshape its...

In the second quarter of 2026, Lennox International reported higher sales of US$1,545.3 million but essentially flat diluted EPS, while also completing a large share repurchase program totaling 16.72 million shares for US$3.45 billion since its October 2014 authorization. The company’s decision to slightly lower full‑year 2026 EPS guidance to US$23.00–US$24.00, despite reaffirming about 8% revenue growth aided by acquisitions, highlights the pressure from weaker residential demand even as...

Hayward Holdings (HAYW) has caught investor attention after its late July 2026 update, which combined solid quarterly results, reaffirmed full year guidance, a completed debt refinancing, and an active share repurchase program. See our latest analysis for Hayward Holdings. Over the past year Hayward Holdings has seen a modest 1 year total shareholder return of 4.22%, while its 90 day share price return of 10.01% suggests momentum has picked up around the July earnings, refinancing, and...